These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8796275)

  • 1. Plasma kallikrein and tissue-type plasminogen activator compete for a common pathway into the liver.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Immunopharmacology; 1996 May; 32(1-3):88-90. PubMed ID: 8796275
    [No Abstract]   [Full Text] [Related]  

  • 2. Participation of a galectin-dependent mechanism in the hepatic clearance of tissue-type plasminogen activator and plasma kallikrein.
    Nagaoka MR; Strital E; Kouyoumdjian M; Borges DR
    Thromb Res; 2002 Nov; 108(4):257-62. PubMed ID: 12617990
    [No Abstract]   [Full Text] [Related]  

  • 3. The hepatic clearance of recombinant tissue-type plasminogen activator decreases after an inflammatory stimulus.
    Nagaoka MR; Kouyoumdjian M; Borges DR
    Braz J Med Biol Res; 2000 Jan; 33(1):119-25. PubMed ID: 10625883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma kallikrein clearance by the liver: a review.
    Borges DR; Kouyoumdjian M
    Braz J Med Biol Res; 1994 Aug; 27(8):2033-41. PubMed ID: 7538375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-mediated clearance of tissue kallikreins by rat liver.
    Borges DR; Kouyoumdjian M; Prado ES; Prado JL
    Adv Exp Med Biol; 1986; 198 Pt A():235-9. PubMed ID: 3643709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The liver is the main organ to clear plasma and tissue kallikreins from rat plasma, in vivo.
    Borges D; Sampaio C; de la Llosa P; Prado JL
    Adv Exp Med Biol; 1986; 198 Pt A():229-33. PubMed ID: 3643708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different receptors mediate the hepatic catabolism of tissue-type plasminogen activator and urokinase.
    Krause J; Seydel W; Heinzel G; Tanswell P
    Biochem J; 1990 May; 267(3):647-52. PubMed ID: 2160232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of serpins and their cognate proteases in muscle after crush injury.
    Festoff BW; Reddy RB; VanBecelaere M; Smirnova I; Chao J
    J Cell Physiol; 1994 Apr; 159(1):11-8. PubMed ID: 8138578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue kallikrein clearance by the liver--effect of plasma components on kallikrein uptake by cultured rat hepatocytes.
    Aoki K; Kamada M; Ikekita M; Kizuki K; Moriya H
    Agents Actions Suppl; 1992; 38 ( Pt 2)():157-64. PubMed ID: 1462824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of the mannose receptor from human liver potentially involved in the plasma clearance of tissue-type plasminogen activator.
    Otter M; Zocková P; Kuiper J; van Berkel TJ; Barrett-Bergshoeff MM; Rijken DC
    Hepatology; 1992 Jul; 16(1):54-9. PubMed ID: 1618483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The vascular plasminogen activator as source of the fibrinolytic potential observed during cardiopulmonary bypass.
    Baños G; de la Peña A; Izaguirre R
    Thromb Res; 1992 Sep; 67(5):579-88. PubMed ID: 1448790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRP and the receptor-mediated endocytosis of plasminogen activators.
    Warshawsky I; Bu G; Schwartz AL
    Ann N Y Acad Sci; 1994 Sep; 737():70-87. PubMed ID: 7944155
    [No Abstract]   [Full Text] [Related]  

  • 13. Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes.
    Ichinose A; Kisiel W; Fujikawa K
    FEBS Lett; 1984 Oct; 175(2):412-8. PubMed ID: 6566616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions.
    Kuiper J; Van't Hof A; Otter M; Biessen EA; Rijken DC; van Berkel TJ
    Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):775-80. PubMed ID: 8611154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic clearance of tissue-type plasminogen activator in rats.
    Emeis JJ; van den Hoogen CM; Jense D
    Thromb Haemost; 1985 Oct; 54(3):661-4. PubMed ID: 3937264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of plasminogen activator, kallikrein and plasma kinins during muscular exercise].
    Malofiejew M; Reutt H; Januszko T; Buluk K
    Pol Tyg Lek; 1966 Nov; 21(48):1833-5. PubMed ID: 5979524
    [No Abstract]   [Full Text] [Related]  

  • 17. Competition between plasminogen and procathepsin B as a probe to demonstrate the in vitro activation of procathepsin B by the tissue plasminogen activator.
    Dalet-Fumeron V; Boudjennah L; Pagano M
    Arch Biochem Biophys; 1996 Nov; 335(2):351-7. PubMed ID: 8914932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular dynamics of human intrafollicular plasma kallikrein and the mechanism of activation of tissue-type plasminogen activator (tPA) in ovarian follicles].
    Kudo T
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):599-611. PubMed ID: 10036617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake and degradation of tissue plasminogen activator in rat liver.
    Einarsson M; Smedsrød B; Pertoft H
    Thromb Haemost; 1988 Jun; 59(3):474-9. PubMed ID: 3142083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between clearance rates of plasma kallikrein and of plasma kallikrein-alpha-macroglobulin complexes by the liver.
    Ogata H; Kouyoumdjian M; Borges DR
    Int J Biochem; 1993 Jul; 25(7):1047-51. PubMed ID: 7689988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.